Skip to main content

Articles

Page 54 of 70

  1. Children with physical disabilities may have an increased risk for obesity and obesity might be a risk factor for inflammatory arthritis. The aims of this study were: to determine the prevalence of obesity in ...

    Authors: Christina F Pelajo, Jorge M Lopez-Benitez and Laurie C Miller
    Citation: Pediatric Rheumatology 2012 10:3
  2. Behcet's is an idiopathic multi-organ syndrome, which may have onset during childhood. Vascular involvement is uncommon, with rarely reported coronary aneurysm formation. We present a case report of a teenager...

    Authors: Philip J Kahn, Yusuf Yazici, Michael Argilla, Monvadi Srichai and Deborah M Levy
    Citation: Pediatric Rheumatology 2012 10:2
  3. Juvenile polyarteritis nodosa (PAN) is a rare, necrotizing vasculitis, primarily affecting small to medium-sized muscular arteries. Cardiac involvement amongst patients with PAN is uncommon and reports of coro...

    Authors: Therese L Canares, Dawn M Wahezi, Kanwal M Farooqi, Robert H Pass and Norman T Ilowite
    Citation: Pediatric Rheumatology 2012 10:1
  4. To investigate the prevalence of cumulative organ damage among Egyptian children with juvenile-onset systemic lupus erythematosus (jSLE) and the relationships between the organ damage and the demographic data,...

    Authors: Samia Salah, Hala M Lotfy, Abir N Mokbel, Ahmed M Kaddah and Nouran Fahmy
    Citation: Pediatric Rheumatology 2011 9:36
  5. For adolescents with a diagnosis of lifelong chronic illness, mastery of self-management skills is a critical component of the transition to adult care. This study aims to examine self-reported medication adhe...

    Authors: Erica F Lawson, Aimee O Hersh, Mark A Applebaum, Edward H Yelin, Megumi J Okumura and Emily von Scheven
    Citation: Pediatric Rheumatology 2011 9:35
  6. Uveitis treatment involves topical corticosteroids along with cycloplegic-mydriatics. Particularly severe cases may require systemic corticosteroids and immunosuppressive drugs. Vernal keratoconjunctivitis (VK...

    Authors: Andrea Taddio, Rolando Cimaz, Roberto Caputo, Cinzia de Libero, Laura Di Grande, Gabriele Simonini, Francesca Mori, Elio Novembre and Neri Pucci
    Citation: Pediatric Rheumatology 2011 9:34
  7. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with pulmonary hemorrhage is rare in childhood. Standard treatment includes corticosteroids and cyclophosphamide (CYC), which is associat...

    Authors: Emily M Baird, Thomas JA Lehman and Stefan Worgall
    Citation: Pediatric Rheumatology 2011 9:33
  8. Idiopathic osteolysis or disappearing bone disease is a condition characterized by the spontaneous onset of rapid destruction and resorption of a single bone or multiple bones. Disappearing bone disorder is a ...

    Authors: Ali Al Kaissi, Sabine Scholl-Buergi, Rainer Biedermann, Kathrin Maurer, Jochen G Hofstaetter, Klaus Klaushofer and Franz Grill
    Citation: Pediatric Rheumatology 2011 9:31
  9. Intravenous immunoglobulin (IVIg) treatment results in an effective response from patients with acute-phase Kawasaki disease (KD), but 16.5% of them remain nonresponsive to IVIg. To address this therapeutic ch...

    Authors: Kei Takahashi, Toshiaki Oharaseki, Tomokazu Nagao, Yuki Yokouchi, Hitomi Yamada, Noriko Nagi-Miura, Naohito Ohno, Tsutomu Saji, Tomio Okazaki and Kazuo Suzuki
    Citation: Pediatric Rheumatology 2011 9:30
  10. Childhood systemic vasculitides are a group of rare diseases with multi-organ involvement and potentially devastating consequences. After establishment of new classification criteria (Ankara consensus conferen...

    Authors: Erkan Demirkaya, Raashid Luqmani, Nuray Aktay Ayaz, Abdulbaki Karaoglu and Seza Ozen
    Citation: Pediatric Rheumatology 2011 9:29
  11. Authors: N Toplak, J Frenkel, S Ozen, F De Benedetti, M Hofer, I Kone-Paut, H Girschick, B Neven, H Ozdogan, J Kummerle-Deschner, J Arostegui, A Simon, S Stojanov, R Vesely, C Wouters, V Hentgen…
    Citation: Pediatric Rheumatology 2011 9(Suppl 1):P303

    This article is part of a Supplement: Volume 9 Supplement 1

  12. Authors: Falcini Fernanda, Stagi Stefano, Cavalli Loredana, Masi Laura, Capannini Serena, Ceri Lorenzo, Matucci Cerinic Marco and Brandi Maria Luisa
    Citation: Pediatric Rheumatology 2011 9(Suppl 1):P159

    This article is part of a Supplement: Volume 9 Supplement 1

  13. Authors: Silvia Magni-Manzoni, Johannes Roth, Paz Collado, Esperanza Naredo, Maria Antonietta D'Agostino, Pietro Merli, Valentina Muratore and Sandrine Jousse-Joulin
    Citation: Pediatric Rheumatology 2011 9(Suppl 1):P47

    This article is part of a Supplement: Volume 9 Supplement 1

  14. Authors: D Holzinger, J Austermann, P Lohse, I Aksentijevich, S Holland, M Gattorno, C Rodríguez-Gallego, S Fessatou, B Isidor, S Tokio, J Bernstein, B Sampson, C Sunderkoetter and J Roth
    Citation: Pediatric Rheumatology 2011 9(Suppl 1):O39

    This article is part of a Supplement: Volume 9 Supplement 1

  15. Authors: B Bader-Meunier, P Hachulla, J Kuemmerle-Deschner, M Gattorno, N Patel, R Preiss, K Lheritier, T Imagawa, R Nishikomori, H Takada, T Heike, T Hara and S Yokota
    Citation: Pediatric Rheumatology 2011 9(Suppl 1):P12

    This article is part of a Supplement: Volume 9 Supplement 1

  16. Authors: Sergio Davì, Bianca Lattanzi, Silvia Rosina, Erkan Demirkaya, Nicolino Ruperto, Alberto Martini, Randy Q Cron and Angelo Ravelli
    Citation: Pediatric Rheumatology 2011 9(Suppl 1):O5

    This article is part of a Supplement: Volume 9 Supplement 1

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    2.5 - 2-year Impact Factor
    3.0 - 5-year Impact Factor
    1.035 - SNIP (Source Normalized Impact per Paper)
    0.732 - SJR (SCImago Journal Rank)

    2023 Speed
    18 days submission to first editorial decision for all manuscripts (Median)
    94 days submission to accept (Median)

    2023 Usage 
    1,095,144 downloads
    691 Altmetric mentions